Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
66.69
+0.10 (+0.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
31
32
Next >
3 Stocks That Could Soar in a Santa Claus Rally
December 25, 2022
These stocks are primed for a holiday surge.
Via
The Motley Fool
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review
December 23, 2022
The market uptrend is under pressure.
Via
Investor's Business Daily
3 Nasdaq Stocks That Are Up 25% in 3 Months
December 23, 2022
Should you jump on the bandwagon and buy these surging stocks?
Via
The Motley Fool
FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
December 22, 2022
Via
Benzinga
Gilead Sciences Snags FDA Approval For Twice-Yearly HIV Shot
December 22, 2022
The twice-yearly option is attractive for patients that don't get adequate treatment from pills alone.
Via
Investor's Business Daily
Could Gilead (GILD) Continue On The Bull Run?
December 17, 2022
Using the Wycoff trading method, we see that Gilead Sciences, Inc (GILD) will likely continue its bullish momentum.
Via
Talk Markets
Beat the Dow Jones With This Unstoppable Dividend Stock
December 12, 2022
Gilead Sciences is a 2022 winner that could stay hot in 2023.
Via
The Motley Fool
Why Is Arcellx (ACLX) Stock Up 25% Today?
December 09, 2022
ACLX stock is usually under the radar, but today it's in the spotlight as Arcellx reveals a team-up with a well-known biotech business.
Via
InvestorPlace
Analyzing Gilead Sciences's Short Interest
December 21, 2022
Gilead Sciences's (NASDAQ:GILD) short percent of float has fallen 15.15% since its last report. The company recently reported that it has 17.56 million shares sold short, which is 1.4% of all regular...
Via
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.
Via
InvestorPlace
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
Via
Benzinga
Why Is Gilead Sciences Stock Sliding Tuesday?
December 20, 2022
Gilead Sciences Inc (NASDAQ: GILD) shares are trading lower Tuesday after the company reported results from its Phase 2 non-small
Via
Benzinga
Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche
December 20, 2022
Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 15 Years
December 08, 2022
Via
Benzinga
Is Gilead Sciences a Buy?
December 08, 2022
This stock has got something to offer both dividend and growth investors.
Via
The Motley Fool
Expert Ratings for Gilead Sciences
December 01, 2022
Via
Benzinga
2 Reasons This Stock Could Outperform in 2023
November 30, 2022
It would be a continuation of this year's showing.
Via
The Motley Fool
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
December 20, 2022
Via
Benzinga
Tuesday Talk: Where is Santa?
December 20, 2022
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found.
Via
Talk Markets
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
December 19, 2022
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.
Via
Talk Markets
Why Merck's $250 Million Investment In Moderna May Have Just Paid Off
December 13, 2022
Merck opted into Moderna's cancer vaccine. Now, the companies have Phase 2 data.
Via
Investor's Business Daily
Top-Notch IPO Stock Arcellx Breaks Out On $325 Million Cancer Tie-Up With Gilead Sciences
December 09, 2022
The company inked a deal worth $325 million and up to $3.9 billion in milestones.
Via
Investor's Business Daily
Gilead's Kite, Arcellx Ink Over $300M Collaboration Pact For Late-Stage Multiple Myeloma Candidate
December 09, 2022
Via
Benzinga
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
-Clinical Data Due Next Week at ASH-
Via
Benzinga
Is Gilead Sciences Stock Still a Buy After Soaring in 2022?
December 08, 2022
Gilead faces some challenges. But there are several reasons to think the stock could keep the momentum going.
Via
The Motley Fool
Gilead Sciences Unusual Options Activity
December 02, 2022
Someone with a lot of money to spend has taken a bearish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review
December 02, 2022
The S&P 500 is fighting for its 200-day, a critical level for the uptrend.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
The Top Healthcare Stocks to Buy With $100
December 01, 2022
Triple-digit growth and innovation go hand-in-hand with these companies.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
During Thursday's session, 108 stocks hit new 52-week highs.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.